The North American Intrauterine Contraceptive Devices (IUCD) market is estimated to grow at a CAGR of 0.3% from 2014 to 2019. The growth of this market is driven by factors such as increasing rate of unplanned pregnancies, effective contraception, fewer side effects of IUCDs, implementation of the Affordable Care Act (ACA), rising initiatives of private firms directed at reducing abortion-related expenses, funds/grants for IUCD products, and technological advancements. Moreover, the rising number of players in this segment and technological advancements are creating growth opportunities for the North American intrauterine contraceptive devices market. However, high cost of treatment, threat of causing pelvic inflammatory infection (PID), threat of causing ectopic pregnancy, high rate of complications in unplanned pregnancies, and the need for compulsory assistance of a medical professional for the insertion of IUCDs is restraining the growth of the IUCD market in North America.
In this report, the North American intrauterine contraceptive devices market has been broadly classified on the basis of types, which include hormonal IUCDs and copper IUCDs. The hormonal IUCD market segment accounts for the largest market share of 83.4% of the North American IUCD market. Factors such as safety, easy removal, lighter periods, and the increasing adoption of hormonal IUD products such as Mirean and Skyla in the U.S. are driving the growth of this market.
Geographically, the U.S. is estimated to command the largest share of 93.1% of the North American IUCD market in 2014, followed by Canada. This market in the U.S. is primarily driven by the Affordable Care Act and technological advancements in the development of IUCDs. However, stringent regulatory and reimbursement policies in the U.S. and the threat of developing PID infections are restraining the growth of the IUCD market in this region.
Complete report is available @ http://www.reportsnreports.com/reports/319515-north-america-intrauterine-contraceptive-devices-market.html .